Harry Büller - Articles and news items

Daiichi Sankyo logo
Daiichi Sankyo logo

Daiichi Sankyo completes enrolment in Hokusai-VTE

Industry news, News / 25 October 2012 / Daiichi Sankyo

Edoxaban is an investigational, once daily, novel oral factor Xa inhibitor…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+